Low dose ct screening for lung cancer: Moving into the clinical arena

Journal of Thoracic Imaging

Volumn 30, Issue 2, 2015, Pages 77-78

  Chiles, Caroline ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELGIUM; BODY MASS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DENMARK; EARLY DIAGNOSIS; EDITORIAL; FOLLOW UP; GERMANY; HEALTH CARE COST; HUMAN; ITALY; LUNG CANCER; LUNG NODULE; NETHERLANDS; QUALITY ADJUSTED LIFE YEAR; RADIATION DOSE; SMOKING; SMOKING CESSATION; SOCIAL STATUS; THORAX RADIOGRAPHY; UNITED KINGDOM; LUNG TUMOR; RADIOGRAPHY;

HUMANS; LUNG NEOPLASMS; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84924061022     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000143     Document Type: Editorial

References (11)

1. National Lung Screening Trial Research T, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
2. Black WC. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis. J Thorac Imaging. 2015;30:79-87.
3. Neumann PJ, Cohen JT, Weinstein MC. Updating costeffectiveness-The curious resilience of the 50, 000-per-QALY threshold. N Engl J Med. 2014;371:796-797.
4. Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014;371:1793-1802.
5. Tammemägi M. Application of risk prediction moDels to lung cancer screening: a review. J Thorac Imaging. 2015;30:88-100.
6. Heuvelmans MA, Vliegenthart R, Oudkerk M. Contributions of the European trials (European Randomized Screening Group) in computed tomography lung cancer screening. J Thorac Imaging. 2015;30:101-107.
7. Horeweg N, Van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-Detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. The Lancet Oncology. 2014.
8. Nawa T, Nakagawa T, Mizoue T, et al. A Decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer. 2012;78:225-228.
9. Nawa T, Nakagawa T, Mizoue T, et al. Low-dose computed tomography screening in Japan. J Thorac Imaging. 2015;30:108-114.
10. McKee BJ, McKee AB, Kitts AB, et al. Low-dose computed tomography screening for lung cancer in a clinical setting: essential elements of a screening program. J Thorac Imaging. 2015;30:115-129.
11. Bartholmai BJ, Koo CW, Johnson GB, et al. Pulmonary nodule characterization, including computer analysis and quantitative features. J Thorac Imaging. 2015;30:139-156